Zinc in PDB 6ydx: Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor
Enzymatic activity of Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor
All present enzymatic activity of Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor:
3.4.11.3;
Protein crystallography data
The structure of Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor, PDB code: 6ydx
was solved by
A.Mpakali,
E.Saridakis,
P.Giastas,
E.Stratikos,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
45.96 /
3.20
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
73.419,
118.631,
141.389,
90.00,
102.77,
90.00
|
R / Rfree (%)
|
27.7 /
31.4
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor
(pdb code 6ydx). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor, PDB code: 6ydx:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 6ydx
Go back to
Zinc Binding Sites List in 6ydx
Zinc binding site 1 out
of 2 in the Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn1102
b:49.3
occ:1.00
|
O33
|
A:ONN1101
|
2.1
|
39.7
|
0.4
|
OE1
|
A:GLU487
|
2.2
|
34.5
|
1.0
|
O33
|
A:ONN1101
|
2.2
|
39.8
|
0.6
|
NE2
|
A:HIS468
|
2.2
|
38.5
|
1.0
|
CE1
|
A:HIS464
|
2.5
|
34.5
|
1.0
|
N34
|
A:ONN1101
|
2.5
|
39.1
|
0.4
|
C31
|
A:ONN1101
|
2.6
|
39.8
|
0.4
|
C31
|
A:ONN1101
|
2.7
|
39.7
|
0.6
|
C32
|
A:ONN1101
|
3.0
|
39.3
|
0.4
|
CD2
|
A:HIS468
|
3.2
|
40.6
|
1.0
|
CE1
|
A:HIS468
|
3.2
|
40.8
|
1.0
|
ND1
|
A:HIS464
|
3.3
|
33.0
|
1.0
|
CD
|
A:GLU487
|
3.3
|
35.2
|
1.0
|
N30
|
A:ONN1101
|
3.4
|
40.6
|
0.6
|
N34
|
A:ONN1101
|
3.4
|
39.8
|
0.6
|
C32
|
A:ONN1101
|
3.5
|
38.7
|
0.6
|
C1
|
A:ONN1101
|
3.5
|
41.4
|
0.6
|
NE2
|
A:HIS464
|
3.6
|
36.7
|
1.0
|
N30
|
A:ONN1101
|
3.7
|
40.4
|
0.4
|
CE2
|
A:TYR549
|
3.8
|
36.3
|
1.0
|
OE2
|
A:GLU487
|
3.8
|
41.0
|
1.0
|
OE1
|
A:GLU431
|
3.8
|
34.7
|
1.0
|
C9
|
A:ONN1101
|
3.9
|
40.2
|
0.6
|
OH
|
A:TYR549
|
4.0
|
34.8
|
1.0
|
C1
|
A:ONN1101
|
4.1
|
41.3
|
0.4
|
ND1
|
A:HIS468
|
4.3
|
41.2
|
1.0
|
CG
|
A:HIS468
|
4.3
|
39.4
|
1.0
|
C9
|
A:ONN1101
|
4.4
|
40.0
|
0.4
|
CZ
|
A:TYR549
|
4.4
|
30.4
|
1.0
|
C35
|
A:ONN1101
|
4.5
|
38.1
|
0.4
|
CG
|
A:GLU487
|
4.5
|
36.5
|
1.0
|
CG
|
A:HIS464
|
4.6
|
35.5
|
1.0
|
C2
|
A:ONN1101
|
4.6
|
43.0
|
0.6
|
CB
|
A:GLU487
|
4.6
|
38.2
|
1.0
|
CD2
|
A:HIS464
|
4.7
|
36.8
|
1.0
|
OE1
|
A:GLU465
|
4.7
|
39.7
|
1.0
|
CA
|
A:GLU487
|
4.8
|
39.2
|
1.0
|
CB
|
A:ALA490
|
4.8
|
32.0
|
1.0
|
CD2
|
A:TYR549
|
4.8
|
32.4
|
1.0
|
OE2
|
A:GLU465
|
4.8
|
33.9
|
1.0
|
C3
|
A:ONN1101
|
4.8
|
44.4
|
0.6
|
C35
|
A:ONN1101
|
4.9
|
38.3
|
0.6
|
C36
|
A:ONN1101
|
4.9
|
39.5
|
0.4
|
CD
|
A:GLU431
|
5.0
|
37.1
|
1.0
|
|
Zinc binding site 2 out
of 2 in 6ydx
Go back to
Zinc Binding Sites List in 6ydx
Zinc binding site 2 out
of 2 in the Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Insulin-Regulated Aminopeptidase Complexed with A Macrocyclic Peptidic Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn1102
b:35.2
occ:1.00
|
OE1
|
B:GLU487
|
2.2
|
33.8
|
1.0
|
NE2
|
B:HIS468
|
2.2
|
32.6
|
1.0
|
O33
|
B:ONN1101
|
2.2
|
37.0
|
0.6
|
NE2
|
B:HIS464
|
2.3
|
36.9
|
1.0
|
O33
|
B:ONN1101
|
2.5
|
45.9
|
0.5
|
CD2
|
B:HIS468
|
2.6
|
32.8
|
1.0
|
CD2
|
B:HIS464
|
3.2
|
36.3
|
1.0
|
CD
|
B:GLU487
|
3.2
|
36.1
|
1.0
|
CE1
|
B:HIS464
|
3.3
|
37.8
|
1.0
|
C1
|
B:ONN1101
|
3.3
|
48.1
|
0.5
|
C31
|
B:ONN1101
|
3.4
|
48.1
|
0.5
|
C31
|
B:ONN1101
|
3.4
|
38.3
|
0.6
|
CE1
|
B:HIS468
|
3.5
|
34.0
|
1.0
|
OE2
|
B:GLU487
|
3.6
|
33.6
|
1.0
|
C1
|
B:ONN1101
|
3.7
|
38.2
|
0.6
|
CG
|
B:HIS468
|
3.9
|
30.2
|
1.0
|
CE2
|
B:TYR549
|
4.0
|
40.1
|
1.0
|
N30
|
B:ONN1101
|
4.1
|
48.5
|
0.5
|
C9
|
B:ONN1101
|
4.2
|
51.5
|
0.5
|
N30
|
B:ONN1101
|
4.3
|
38.2
|
0.6
|
ND1
|
B:HIS468
|
4.3
|
30.6
|
1.0
|
C9
|
B:ONN1101
|
4.3
|
37.2
|
0.6
|
CG
|
B:HIS464
|
4.3
|
33.3
|
1.0
|
C32
|
B:ONN1101
|
4.3
|
48.5
|
0.5
|
N34
|
B:ONN1101
|
4.4
|
47.5
|
0.5
|
ND1
|
B:HIS464
|
4.4
|
31.3
|
1.0
|
C32
|
B:ONN1101
|
4.4
|
39.0
|
0.6
|
CG
|
B:GLU487
|
4.4
|
32.9
|
1.0
|
N34
|
B:ONN1101
|
4.4
|
39.2
|
0.6
|
OE2
|
B:GLU465
|
4.5
|
29.8
|
1.0
|
C2
|
B:ONN1101
|
4.5
|
49.5
|
0.5
|
OE2
|
B:GLU431
|
4.5
|
35.7
|
1.0
|
CA
|
B:GLU487
|
4.5
|
31.8
|
1.0
|
CB
|
B:GLU487
|
4.6
|
31.9
|
1.0
|
OH
|
B:TYR549
|
4.6
|
40.3
|
1.0
|
CB
|
B:ALA490
|
4.6
|
29.0
|
1.0
|
OE1
|
B:GLU465
|
4.7
|
36.3
|
1.0
|
C2
|
B:ONN1101
|
4.8
|
38.9
|
0.6
|
CZ
|
B:TYR549
|
4.8
|
38.5
|
1.0
|
CD2
|
B:TYR549
|
4.8
|
35.2
|
1.0
|
CD
|
B:GLU431
|
4.9
|
36.1
|
1.0
|
CD
|
B:GLU465
|
5.0
|
35.1
|
1.0
|
C3
|
B:ONN1101
|
5.0
|
41.0
|
0.6
|
|
Reference:
A.Mpakali,
E.Saridakis,
P.Giastas,
Z.Maben,
L.J.Stern,
M.Larhed,
M.Hallberg,
E.Stratikos.
Structural Basis of Inhibition of Insulin-Regulated Aminopeptidase By A Macrocyclic Peptidic Inhibitor. Acs Med.Chem.Lett. V. 11 1429 2020.
ISSN: ISSN 1948-5875
PubMed: 32676150
DOI: 10.1021/ACSMEDCHEMLETT.0C00172
Page generated: Tue Oct 29 11:28:18 2024
|